Former Technical Adviser at NICE and current MedTech Evidence and Technical Director at Device Access, Dr Christopher Pomfrett explains what the National Institute of Health and Care Excellence is and why it is beneficial for MedTech companies to get NICE recommendation.
Device Access is a market access consultancy specialising in market access strategy for MedTech NHS reimbursement and adoption. We offer services ranging from a national to local level, including patient pathway analysis, reimbursement coding and economic modelling.
Visit our website deviceaccess.co.uk/
Follow us on LinkedIn www.linkedin.com/company/device-access-uk-ltd
Market Access, Accelerated
Device Access